Treatment of three patients with systemic mastocytosis with interferon alpha-2b

Leukemia and Lymphoma

Volumn 22, Issue 5-6, 1996, Pages 501-508

  Worobec, Alexandra S ^a,c   Kirshenbaum, Arnold S ^a   Schwartz, Lawrence B ^b   Metcalfe, Dean D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Interferon alpha; Mastocytosis; Treatment

Indexed keywords

ALPHA2B INTERFERON; CD34 ANTIGEN; HISTAMINE; LACTATE DEHYDROGENASE; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT GAMMA INTERFERON; STEM CELL FACTOR; TRYPTASE;

ADULT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; DRUG DEPENDENCE; FEMALE; HEPATOMEGALY; HISTAMINE RELEASE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; MALE; MAST CELL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SYSTEMIC MASTOCYTOSIS; URTICARIA PIGMENTOSA;

EID: 0029826042     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054789     Document Type: Article

References (40)

1. Austen, K. F. (1992) Systemic mastocytosis. New Eng. J. Med., 326, 639-340.
2. Metcalfe, D. D. (1991) Classification and diagnosis of mastocytosis, current status. J. Invest. Dermatol., 96, 2S-4S.
3. Metcalfe, D. D., Costa, J. J., Burd, P. R. (1992) Mast cells and basophils. In Inflammation: Basic Principles and Clinical Correlates, edited by J. I. Gallin, I. M. Goldstein and R. Snyderman, pp. 709-725. New York: Raven Press, Ltd.
4. Horny, H. P., Ruck, M., Wehrmann, M., Kaiserling, E. (1990) Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurence of myeloproliferative disorders. Br. J. Haematol, 76, 186-193.
5. Lawrence, J. B., Friedman, B. S., Travis, W. D., Chinchilli, V. M., Metcalfe, D. D., Gralnick, H. R. (1991) Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis. Am. J. Med., 91, 612-624.
6. Metcalfe, D. D. (1991) The treatment of mastocytosis: current status. J. Invest. Dermatol., 96, 55S-59S.
7. Kluin-Nelemans, H. C., Jansen, J. H., Bruekelman, H., et al. (1992) Response to interferon alpha-2b in a patient with systemic mastocytosis. New Engl. J. Med., 326, 619-623.
8. Kirshenbaum, A. S., Kessler, S. W., Goff, J. P., Metcalfe, D. D. (1991) Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J. Immunol., 146, 1410-1415.
9. Einhorn, S. and Strander, H. (1993) Interferon treatment of human malignancies-a short review. Med. Oncol. Tumor Pharmacother., 10, 25-29.
10. Griesshammer, M., Hehlmann, R., Hochbaus, A. et al. (1993) Interferon in chronic myeloid leukemia. Ann. Hematol., 67, 101-106.
11. Niederle, N., Kloke, O., Wnadl, U. B., Becher, R., Moritz, T., Opalka, B. (1993) Long-term treatment of chronic myelogenous leukemia with different interferons: results from three studies. Leukemia and Lymphoma, 9, 111-119.
12. Pardini, S., Bosincu, L., Bonfigli, S., Dore, F., Longinotti, M. (1991) Anaphylactic-like syndrome in systemic mastocytosis treated with alpha-2-interferon. Acta. Haematol., 85, 220.
13. Sewall, K. L. (1993) Immunotherapy and other novel therapies, including biologic response modifiers, apheresis and dietary modifications. Curr. Opin. Rheumatol., 5, 293-298.
14. Schwartz, L. B., Bradford, T. R., Rouse, C. et al. (1994) Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J. Clin. Immunol., 14, 190-204.
15. - cell population. Blood, 84, 2489-2496.
16. Chen, C. C., Andrich, M. P., Mican, J. M., Metcalfe, D. D. (1994) A retrospective analysis of bone scan abnormalities in 73 patients with mastocytosis: correlation with disease category and prognosis. J. Nucl. Med., 35, 1471-1475.
17. Griesinger, F., Bergmann, L., Mitrou, P. S., Hoelzer, D. (1987) Interferons in the treatment of malignant mastocytosis (MM) and CMMol developing in MM. Blut, 55, 309.
18. Czarnetzki, B. M., Algermissen, B., Jeep, S., et al. (1994) Interferon treatment of patients with chronic urticaria and mastocytosis. J. Am. Acad. Dermatol., 3, 500-501.
19. Gutterman, J. U. (1994) Cytokine therapeutics: lessons from interferon alpha. PNAS, 91, 1198-1205.
20. Lee, S. B. and Esteban, M. (1994) The inteferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology, 199, 491-496.
21. Lee, T. G., Tomita, J., Hovanessian, A. G., Katze, M. G. (1992) Characterization and regulation of the 58,000 dalton cellular inhibitor of the interferon-induced, dsRNA-activated protein kinase. J. Biol. Chem., 267, 14238-14243.
22. Merimsky, O., Chaitnik, S. (1992) Neurotoxicity of interferon-alpha. Anticancer Drugs, 19, 3, 567-570.
23. Aul, C., Gatterman, N., Schneider, W. (1991) Treatment of advanced myelodysplastic syndrome with recombinant interferon alpha-2b. Eur. J. Haematol., 46, 11-16.
24. Avvisati, G., Mandelli, F. (1992) The role of interferon-alpha in the management of myelomatosis. Hematol. Oncol. Clin. North Am., 6, 395-405.
25. Coutant, G., Bletry, O., Prin, L., et al. (1993) Treatment of hypereosinophilic syndromes of myeloproliferative expression with the combination of hydroxyurea and interferon alpha. Apropos of 7 cases. Ann. Med. Interne. (Paris), 144, 243-250.
26. Peschel, C., Aman, M. J., Rudolf, G., Aulitzky, W. E., Huber, C. (1993) Regulation of the cytokine network by interferon: a potential mechanism of interferon in chronic myelogenous leukemia. Seminars in Hematol., 30, 28-31.
27. Petska, S., Langer, J. A., Zoon, K. C., Samuel, C. E. (1987) Inteferons and their actions. Ann. Rev. Biochem., 56, 727-777.
28. Lengyel, P. (1993) Tumor suppressor genes: news about the inteferon connection. PNAS, 90, 5893-5895.
29. Raefsky, E. L., Platanias, L. C., Zoumbos, N. C., Young, N. S. (1985) Studies of interferon as a regulator of hematopoietic cell proliferation. J. Immunol., 135, 2507-2512.
30. Fisher, P. B. and Grand, S. (1985) Effects of interferon on differentiation of normal and tumor cells. Pharmacol. Ther., 27, 143-166.
31. Judware, R. and Petryshyn, R. (1991) Partial characterization of a cellular factor that regulates the double-stranded RNA-dependent eIF-2a kinase in 3T3-F442A fibroblasts. Mol. Cell Biol., 11, 3259-3267.
32. Zhang, K., Kumar, R. (1994) Interferon-alpha inhibits cyclin E- and cyclin D1-dependent CDK-2 kinase activity associated with RB protein and E2Fin Daudi cells. Biochem. Biophys. Res. Commun., 200, 522-528.
33. Sissolak, G., Hoffbrand, A. V., Mehta, A. B., Ganeshaguru, K. (1993) Interferon-alpha inducible2′-5′ oligoadenylate synthetase transcripts in lymphoid and myeloid leukemias. Leukemia, 7, 712-716.
34. Williams, B. R. (1991) Signal transduction and transcriptional regulation of interferon-alpha stimulated genes. J. Interferon Res., 11, 207-213.
35. Vilcek, J. (1993) Recent progress in the elucidation of interferon alpha/beta and interferon gamma actions. Seminars in Hematol., 30, 9-10.
36. Pfeffer, L. M. and Colamonici, O. R. (1991) Transmembrane signalling by inteferon-alpha. Pharmacol. Ther., 52, 149-157.
37. Wood, J. N. and Hovanessian, A. G. (1979) Interferon enhances 2′-5′ A synthetase in embryonal carcinoma cells. Nature, 282, 74-76.
38. Clauss, I. M., Vandenplas, B., Walthelet, M. G. et al. (1990) Analysis of interferon-inducible genes in cells of chronic myeloid leukemia. Patients responsive or resistant to an interferon-alpha treatment. Blood, 76, 2337-2342.
39. James, R. I., Menaya, J., Hudson, K. et al. (1992) Role of protein kinase C in induction of gene expression and inhibition of cell proliferation by interferon alpha. Eur. J. Biochem., 209, 813-822.
40. Pulik, M., Lionnet, F., Petit, A., Genet, P., Gaulier, A. (1994) Long-term response to Interferon-α in a patient with systemic mastocytosis and chronic myelomonocytic leukemia. J. Am. Hematol., 47, 66.